Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2008 Q1- Text added to 2008 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
anaplastic, arm, Asia, asset, AU, beracizumab, carrying, Code, committee, constituted, cooling, copy, disruptive, distributor, doubling, EMEA, Eric, Error, EUR, extinguishment, extraordinary, Fairly, FAS, FSP, GAAP, Genetech, genome, glioblastoma, glioma, intangible, Intermittent, issuer, kilogram, Latin, leucovirin, lymphopenia, MAA, multiforme, nongovernmental, ordinary, orVelocImmune, ourVelociGene®orVelocImmune, ourVelociGene®technology, ourVelocImmune®human, ourVelocImmune®license, ourVelocImmune®technology, Oversight, oxaliplatin, Pacific, premium, published, RECIST, reconcile, reconciled, redemption, relapsed, renewal, repeat, repurchase, repurchased, Shooter, stimuli, Subscription, theVelocImmune, transition, transitioning, unknown, unpaid, women
Removed:
adenocarcinoma, arrange, blinded, compare, continuing, Countering, death, episode, eventually, feature, inhibiting, Macugen, mild, mutation, NSCLA, Orphan, oxygen, preexisting, promoting, provoke, refinance, refinancing, registration, regression, remove, resulted, stimulate, temperature, vessel, waste
Valuein 2008 Q1 filing- Value in 2008 Q2 filing
Original filings
Filing view